More Press Releases

View Older Stories View Newer Stories

Dec 9, 2025 07:45AM Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market
Dec 9, 2025 07:45AM Ajust Design Adds Strategic Communication Practice as Private Equity Firms Encounter Growing Competition for Capital
Dec 9, 2025 07:45AM Ability Biotherapeutics Appoints Angèle Maki, PhD, as Chief Business Officer
Dec 9, 2025 07:45AM ZenaTech Enters UK Market Closing Drone-as-a-Service Acquisition of Casado Design Ltd., Expanding to the Growing Telecom Tower Design and Infrastructure Sector
Dec 9, 2025 07:45AM Greene Concepts Reflects on Its Journey of Renewal, Resilience, and National Growth with Be Water(TM)
Dec 9, 2025 07:44AM Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple
Dec 9, 2025 07:40AM OS Therapies Announces Successful pre-Marketing Authorisation Application Meeting with UK MHRA Regarding the Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected
Dec 9, 2025 07:25AM CHARBONE Taps Air Liquide Veteran Ahead of First Revenue From Flagship Project
Dec 9, 2025 07:40AM Elanco Investor Day Defines New Era as Sustainable Growth Company
Dec 9, 2025 07:38AM MassMedia Accelerates Paid Media Capabilities With Leadership Appointment of Kristen Carter
Dec 9, 2025 07:34AM BibleVerseArt.co Launches a New Collection of Faith-Inspired Wall Art for Every Home
Dec 9, 2025 07:34AM PropertyManagementMalta.co Introduces Full-Service Property Management for Maltese Rentals
Dec 9, 2025 07:35AM From a Simple Idea to a Global Standard: EV Blocks Founder Wins Global Entrepreneur of the Year 2025
Dec 9, 2025 07:34AM Solar A/S: No. 19 2025 Major shareholder announcement
Dec 9, 2025 07:33AM Danske Bank A/S, transactions by persons discharging managerial responsibilities
Dec 9, 2025 07:30AM Valkea Resources Strengthens the Bulk-Tonnage Gold Potential of the Koivu Zone at the Paana Project, Northern Finland
Dec 9, 2025 07:30AM Kenorland Minerals Provides an Exploration Update
Dec 9, 2025 07:30AM REPEAT – QGold to Host Live Webinar to Discuss Corporate Update
Dec 9, 2025 07:30AM Revival Gold Provides Update and Latest Results From Drilling at the Mercur Gold Project in Utah
Dec 9, 2025 07:30AM AGF Management Limited Declares Fourth Quarter 2025 Dividend
Dec 9, 2025 07:30AM Recordati Rare Diseases Announces Real-World Data on Long-Term Safety of ENJAYMO® (sutimlimab-jome) in Cold Agglutinin Disease and Cold Agglutinin Syndrome (CAD/CAS) at American Society of Hematology
Dec 9, 2025 07:30AM Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-naïve CLL/SLL
Dec 9, 2025 07:30AM MarketAxess Announces Medium-Term Financial Targets¹ Increases Stock Repurchase Authorization to $505 million Intends to Effect an Accelerated Stock Repurchase
Dec 9, 2025 07:30AM Gold Reserve Provides Update in CITGO Sale Process: Gold Reserve Files Statement in Support of Stay Pending Appeal
Dec 9, 2025 07:30AM Pirtobrutinib Outperforms Bendamustine Plus Rituximab for Previously Untreated CLL/SLL
Dec 9, 2025 07:30AM Soluna Announces Monthly Business Update
Dec 9, 2025 07:30AM Tec-Dara Combination Offers Substantial Improvement Over Standard Second-Line Therapies for Relapsed or Refractory Multiple Myeloma
Dec 9, 2025 07:30AM Hess Midstream LP Announces 2026 Guidance, Extends Return of Capital Program
Dec 9, 2025 07:30AM Kelonia Therapeutics Presents First-in-Human Data From Phase 1 inMMyCAR Study of KLN-1010 in vivo BCMA CAR-T Therapy at the American Society of Hematology (ASH) 2025 Annual Meeting
Dec 9, 2025 07:30AM Novel Agent Ianalumab Added to Standard Therapy Extends Time to Treatment Failure in Patients with Previously Treated Immune Thrombocytopenia
Dec 9, 2025 07:30AM Drug Reduced Need for Blood Transfusions During Hospitalization for Non-Cardiac Surgery
Dec 9, 2025 07:15AM Noble Mineral Exploration Inc. Announces Diamond Drill Program Which has Commenced in the Timmins Area
Dec 9, 2025 07:30AM Menlo Ventures’ 2025 State of Generative AI Report: Enterprise Investment Hit $37B in 2025, Tripling in One Year
Dec 9, 2025 07:30AM ALT5 Sigma Corporation Provides Corporate Update
Dec 9, 2025 07:30AM XCharge North America Selected by Cellerate Power to Deploy Vermont's Fastest EV Chargers
Dec 9, 2025 07:30AM Accomplished Communications Leader Ann Hemingway Joins Sam Brown as Managing Director, Account Services
Dec 9, 2025 07:30AM Pariveda Named a 2025 Geo and Global AWS Partner Award Finalist
Dec 9, 2025 07:30AM Real Expands Southern California Footprint as Top Producer Freeman Wang and 50-Agent Team Join the Brokerage
Dec 9, 2025 07:30AM Pariveda Awarded a 2025 AWS Partner Award
Dec 9, 2025 07:30AM NanoXplore Announces Nima Moghimian as Chief Technology Officer
Dec 9, 2025 07:30AM Bed Bath & Beyond Appoints Nora Gomez as Chief Merchandising Officer
Dec 9, 2025 07:30AM Plus Therapeutics Announces Expansion of CNSide Team and Issuance of Inducement Grants
Dec 9, 2025 07:30AM Cronos to enter the Netherlands with acquisition of Europe’s largest adult-use cannabis company
Dec 9, 2025 07:30AM BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout
Dec 9, 2025 07:30AM GURU Organic Energy Continues Its Record-Breaking Streak on Amazon During Black Friday-Cyber Monday
Dec 9, 2025 07:30AM Edible Garden Preliminary Sales Results During Key Thanksgiving Time Period Increased 26.9% in 2025
Dec 9, 2025 07:30AM 2025 IRS IRIS CSV Generator and 1099 E-Filing Capabilities Unveiled by Real Business Solutions for the 2026 Tax Season
Dec 9, 2025 07:30AM Capstone Strengthens North American Presence and Achieves Key Milestones in Canadian Stone Industries Integration
Dec 9, 2025 07:30AM SideChannel Announces Anna Seacat Appointed to Board of Directors
Dec 9, 2025 07:30AM Novartis ianalumab significantly extends disease control in patients with immune thrombocytopenia with only four once-monthly doses
View Newer Stories View Older Stories